FDA to Convene Pharmacy Compounding Advisory Committee in July The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York What is a 503B outsourcing facility, and why are so many of them uninspected by FDA? Partnership for Safe Medicines Pharmacy Purchasing & Products Magazine BPC 157 Complete Guide: Dosing & 2026 Status The Peptide Toolkit The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York